In the BioHarmony Drug Report Database

"Preview" Icon

Alvimopan

Entereg (alvimopan) is a small molecule pharmaceutical. Alvimopan was first approved as Entereg on 2008-05-20. It is known to target kappa-type opioid receptor, mu-type opioid receptor, and delta-type opioid receptor. Entereg’s patent is valid until 2030-02-12 (FDA).

 

Trade Name

 

Entereg
 

Common Name

 

alvimopan
 

ChEMBL ID

 

CHEMBL270190
 

Indication

 

 

Drug Class

 

Image (chem structure or protein)

Alvimopan structure rendering